Revised OOS Guidance from FDA
FDA has published a revised version of the Guidance on “Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production“ on 16 May 2022.
GMP Consultants can provide you with a word by word comparison of the 2006 vs 2022 documents.
If you would like to purchase a copy of the comparative assessment, please contact [email protected]